| [1] Fujii H,Kawada N. Fibrogenesis in alcoholic liver disease [J].World J Gastroenterol,2014,20(25):8048-8054.[2] Yamamoto M,Takeda K.Current views of toll-like receptor signaling pathways [J].Gastroenterol Res Prac,2010,2010(1):1-8.[3] Szabo G,Bala S.Alcoholic liver disease and the gut-liver axis [J].World J Gastroenterol,2010,16(11):1321-1329.[4] Roh YS,Seki E.Tole-like receptors in alcoholic liver disease,non-alcoholic steatohepatitis and carcinogenesis [J].J Gastroenterol Hepatol,2013,28(suppl 1):38-42.[5] Guo J,Friedman SL.Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis [J].Fibrogenesis Tissue Repair,2010,3:21.doi:10.1186/1755-1536-3-21.[6] Kawasaki T,Kawai T.Toll-like receptor signaling pathways [J].Front Immunol,2014,5(461):1-8.[7] Kasar V,Odin JA.Toll-like receptors and liver injury [J].Liver Int,2014,34(2):184-196.[8] El Kasmi KC,Anderson AL,Devereaux MW,et al.Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury [J].Hepatology,2012,55(5):1518-1528.[9] Seo YY,Cho YK,Bae JC,et al.Tunor necrosis factor-α as a predictor for the development of nonalcoholic fatty liver disease:A 4-year follow-up study[J].Endocrinal Metab,2013,28(1):41-45.[10] McDaniel K1,Herrera L,Zhou T,et al.The functional role of microRNAs in alcoholic liver injury [J].J Cell Mol Med,2014,18(2):197-207.[11] Wang Y,Liu Y,Kirpich I,et al.Lactobacillus rhamnosus GG reduces hepatic TNFα production and inflammation in chronic alcohol-induced liver injury [J].J Nutr Biochem,2013, 24(9):1609-1615.[12] Petrasek J,Bala S,Csak T,et al.IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice [J].J Clin Invest,2012,122(10):3476-3489.[13] Mathews S,Gao B.Therapeutic potential of interleukin 1 inhibitors in the treatment of alcoholic liver disease [J].Hepatology,2013, 57(5):2078-2080.[14] Ishihara K,Harano T.IL-6 in autoimmune disease and chronic inflammatory proliferative disease [J].Cytokine Growth Factor Rev,2001,13(2):357-368.[15] He G,Karin M.NF-kappa B and STAT3-key players in liver inflammation and cancer[J].Cell Res,2011,21(1):159-168.[16] Miller AM,Wang H,Bertola A,et al.Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice [J].Hepatology,2011, 54(3):846-856.[17] Seki E,De Minicis S,Osterreicher CH,et al.TLR4 enhances TGF-beta signaling and hepatic fibrosis [J].Nat Med,2007, 13(11):1324-1332. |
